Sanofi suspends recruitment for coronavirus clinical trials testing hydroxychloroquine

The French drugmaker is also putting a hold on supplying the drug on off-label use to treat Covid-19 until safety concerns are cleared by the World Health Organization.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.